Astute Medical Raises $13M for Protein Biomarker Dx Development | GenomeWeb

Protein biomarker firm Astute Medical said this week that it has secured $13 million in financing.

The funding is an extension of a $26.5 million Series B round completed in May 2010 (PM 5/14/2010). The company also raised $6.2 million in a Series A round in 2008.

The $13 million financing included existing investors Domain Associates, Delphi Ventures, De Novo Ventures, and Johnson & Johnson Development.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.